We are developing a blood-based diagnostic solution for breast cancer, offering a revolutionary, patient-friendly approach to detection, monitoring, and management. While blood-based diagnostics hold great promise, they are not yet a complete replacement for traditional methods like Fine Needle Aspiration Cytology (FNAC), which can cause tumor cell migration, potentially worsening the disease. Early detection, however, transforms breast cancer from a life-threatening condition to one that is highly treatable. This empowers both patients and healthcare providers to act quickly, offering the best opportunity for a full recovery and long-term survival.